Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema. [PDF]
J Clin MedLiu DY +14 more
europepmc +1 more source
Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes. [PDF]
Eye (Lond)Brown FE, Mitra M.
europepmc +1 more source
Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. [PDF]
Clin OphthalmolMansour HA +37 more
europepmc +1 more source
Discordance Between Eye-Specific Clinical Outcomes and Patient-Reported Visual Function After Faricimab Treatment for Neovascular Age-Related Macular Degeneration: A Two-Case Report. [PDF]
Vision (Basel)Pařilová T, Hejsek L, Hodačová L.
europepmc +1 more source
Effectiveness and safety of intravitreal faricimab for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis. [PDF]
Int J Retina VitreousAlseneid A, Bhindi S, Saleki M, Baker D.
europepmc +1 more source
Faricimab for Diabetic Macular Edema in Eyes Vitrectomized for Proliferative Diabetic Retinopathy: A 12-Month Retrospective Study. [PDF]
J Clin MedYoon K +4 more
europepmc +1 more source
Faricimab for treatment-naïve nAMD: 1- and 2-year outcomes and PS-OCT polarimetric entropy. [PDF]
Int OphthalmolKatabami T +7 more
europepmc +1 more source
Real-world outcomes of faricimab in treatment-naïve diabetic macular edema: The Middle East perspective. [PDF]
Saudi J OphthalmolAlBloushi AF +9 more
europepmc +1 more source